Niki BioSolutions, Inc. (NIKI)

NASDAQ: NIKI · Real-Time Price · USD

6.90

-0.64 (-8.49%)

At close: Aug 28, 2026, 4:00 PM EDT

6.92

+0.02 (0.29%)

After-hours: Aug 28, 2026, 7:45 PM EDT

Niki BioSolutions Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	1.83	3.45	0.87	2.01	1.88	8.13
Short-Term Investments	-	-	-	-	0.1	0.24
Cash & Short-Term Investments	1.83	3.45	0.87	2.01	1.99	8.37
Cash Growth	-33.47%	294.96%	-56.41%	1.02%	-76.28%	-73.75%
Accounts Receivable	-	-	-	0.05	0.17	0.08
Other Receivables	0.2	-	0	0.02	0.34	0.17
Receivables	0.2	-	0	0.07	1.39	3.61
Inventory	-	-	-	-	0.03	0.04
Prepaid Expenses	-	0.06	0.07	0.1	0.22	0.22
Restricted Cash	-	-	-	-	3.13	0.13
Other Current Assets	-	0.08	0.01	0.3	0.32	0.33
Total Current Assets	2.04	3.59	0.96	2.48	7.07	12.69
Property, Plant & Equipment	-	-	-	1.85	3.17	3.89
Long-Term Investments	15.1	15.1	15.1	16.1	9.74	4.16
Other Intangible Assets	-	-	-	0.15	0.19	0
Other Long-Term Assets	-	-	0.07	0.07	0.69	1.17
Total Assets	17.13	18.69	16.13	20.64	20.87	21.91

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	0.92	0.06	0.01	0.02	0.12	0.14
Accrued Expenses	-	1.09	0.98	1.96	6.06	4.04
Short-Term Debt	3.51	3.42	3.24	-	6.01	-
Current Portion of Leases	-	0.02	0.1	0.13	0.31	0.19
Other Current Liabilities	0.08	-	0	-	0	0.01
Total Current Liabilities	4.51	4.59	4.34	2.1	12.5	4.38
Long-Term Debt	-	-	-	3.06	0.5	-
Long-Term Leases	-	-	0.01	0.1	0.03	0.02
Other Long-Term Liabilities	0.19	0.35	-	-	-	-
Total Liabilities	4.7	4.95	4.35	5.26	13.03	4.4

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0	0	0	0	35.71	35.64
Additional Paid-In Capital	97	97	93.47	93.02	45.31	43.51
Retained Earnings	-75.12	-73.79	-72.43	-68.16	-65.34	-55.54
Comprehensive Income & Other	-0.1	-0.09	0.09	-0.01	0.03	-0
Total Common Equity	21.79	23.12	21.13	24.85	15.71	23.61
Minority Interest	-9.35	-9.37	-9.36	-9.46	-7.88	-6.1
Shareholders' Equity	12.43	13.74	11.78	15.38	7.83	17.51
Total Liabilities & Equity	17.13	18.69	16.13	20.64	20.87	21.91

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	3.51	3.44	3.35	3.28	6.85	0.22
Net Cash (Debt)	-1.67	0.01	-2.48	-1.28	-4.87	8.15
Net Cash Growth	-	-	-	-	-	-72.08%
Net Cash Per Share	-2.13	0.01	-4.55	-2.83	-13.64	23.27
Filing Date Shares Outstanding	0.81	0.81	0.71	0.55	0.36	0.36
Total Common Shares Outstanding	0.81	0.81	0.56	0.52	0.36	0.36
Working Capital	-2.48	-1	-3.38	0.38	-5.44	8.31
Book Value Per Share	26.75	28.38	37.68	47.95	44.00	66.24
Tangible Book Value	21.79	23.12	21.13	24.7	15.52	23.6
Tangible Book Value Per Share	26.75	28.38	37.68	47.67	43.47	66.22
Machinery	-	-	-	4.81	6.85	4.77
Construction In Progress	-	-	-	-	-	1.9
Leasehold Improvements	-	-	-	0.54	0.54	0.54